Protocol of a prospective study for the combination treatment of Shu-Gan-jian-Pi decoction and steroid standard therapy in autoimmune hepatitis patients.

Autor: Chi XL; Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China. chixiaolingqh@163.com., Xiao HM; Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China., Xie YB; Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China., Cai GS; Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China., Jiang JM; Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China., Tian GJ; Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China., Shi MJ; Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China., Wu SD; Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China., Zhao PT; Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China., Chen HJ; Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China.
Jazyk: angličtina
Zdroj: BMC complementary and alternative medicine [BMC Complement Altern Med] 2016 Dec 07; Vol. 16 (1), pp. 505. Date of Electronic Publication: 2016 Dec 07.
DOI: 10.1186/s12906-016-1486-1
Abstrakt: Background: Prednisone plus azathioprine is considered the mainstay of therapy in the current recommendations for autoimmune hepatitis (AIH). However, it does not provide good benefits for AIH patients because of its serious side effects. Therefore, more and more AIH patients prefer to seek for traditional Chinese medicine (TCM) to manage their symptoms and reduce the side effects of steroids in China. Shu-Gan-Jian-Pi Decoction is a popular used Chinese herbal formula in Guangdong province of China, which has demonstrated the effect of improving efficacy and reducing side effects of corticosteroids in AIH patients. The aim of this study is to evaluate the effects of Shu-Gan-Jian-Pi Decoction combined with steroid in AIH patients. So, this study aims to explore whether the combination treatment of Shu-Gan-Jian-Pi Decoction and steroid standard therapy could improve the clinical management of AIH.
Methods: A prospective non-randomized study on AIH will be conducted between October 2015 and June 2017 in Guangdong Provincial hospital of Chinese medicine. Eligible AIH patients will be classified as the case group (n = 66) and the control group (n = 66) based on the interventions. Patients taking Shu-Gan-Jian-Pi Decoction combined with prednisone and azathioprine will be in the case group and those taking prednisone and azathioprine will be in the control group. The whole study will last 48 weeks, including a 24-week observation period and a 24-week follow-up period. The primary outcome was complete response to therapy, defined as complete biochemical remission at the patient's last visit of observation period and the absence of predefined steroid-specific side effects throughout treatment.
Discussion: This trial will evaluate the efficacy and safety of Shu-Gan-Jian-Pi Decoction combined with prednisone and azathioprine on AIH patients. The achievement of this trial will provide evidence-based data for Shu-Gan-Jian-Pi Decoction, which could provide good benefits for AIH patients.
Trial Registration: Chinese Clinical Trial Registry: ChiCTR-OOC-15006155 . Registration date: 28 March 2015.
Databáze: MEDLINE
Externí odkaz: